Gastrointestinal cancer
Conditions
Interventions
Participants will view a standardized educational video on safe handling of oral anticancer agents at home, followed by pharmacist-led question-and-answer counseling and teach-back. Knowledge and self
Sponsors
The Cancer Institute Hospital of Japanese Foundation for Cancer Research
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients with gastrointestinal cancer who are chemotherapy-naive and newly start a regimen including oral anticancer agents during hospitalization. 2. Patients who provide written informed consent to participate in the study. 3. Patients aged 18 years or older on the date of registration.
Exclusion criteria
Exclusion criteria: 1. Patients who have previously received education on exposure prevention for anticancer agents. 2. Patients who have difficulty viewing the video because of visual impairment, hearing impairment, or other reasons. 3. Patients with cognitive impairment. 4. Patients who do not provide informed consent. 5. Patients judged to have difficulty participating in the study because of clinically significant psychiatric or neurological symptoms. 6. Patients judged by the physician to be unsuitable for enrollment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Core adherence rate to safe handling practices for oral anticancer agents at home at T1, defined as the second treatment cycle after discharge in the outpatient or inpatient setting. The rate will be assessed using five core behavior items (G1, G2, G3, G9, and G10). Each "yes" response will be scored as 1 and each "no" response as 0 to calculate a core adherence score (0-5), which will be converted to a percentage (0-100%). The mean and 95% confidence interval will be calculated. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Change in knowledge score before and after video-based education (T1-T0). 2. Change in self-efficacy score before and after video-based education (T1-T0). 3. Satisfaction, acceptability, and perceived usefulness of video-based education. 4. Proportion of patients with increased anxiety after video viewing. 5. Proportion of patients with decreased motivation for treatment after video viewing. 6. Associations between adherence rate and knowledge score, self-efficacy score, and patient characteristics. 7. Item-level applicability and adherence rates among applicable participants. 8. Estimated reduction in pharmacist counseling time and personnel costs | — |
Countries
Japan
Contacts
Public ContactTanigawa Hiromu
The Cancer Institute Hospital of Japanese Foundation for Cancer Research Department of Pharmacy
Outcome results
None listed